Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxia-inducible factors in vitro

British Journal of Anaesthesia

Volumn 114, Issue 5, 2015, Pages 825-830

  Shi, Q Y ^a   Zhang, S J ^b   Liu, L ^a   Chen, Q S ^a   Yu, L N ^a   Zhang, F J ^a   Yan, M ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

AC133 antigen; glioma; hypoxia inducible factor 1 ; neoplastic stem cells; sevoflurane

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CD133 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROTEIN KINASE B; SEVOFLURANE; SMALL INTERFERING RNA; VASCULOTROPIN; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; VASCULOTROPIN A;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; GLIOMA STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INVESTIGATIVE PROCEDURES; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING; CANCER STEM CELL; DRUG EFFECTS; GLIOMA; PATHOLOGY; PROCEDURES; TUMOR CELL CULTURE;

ANESTHETICS, INHALATION; BLOTTING, WESTERN; CELL PROLIFERATION; GLIOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IN VITRO TECHNIQUES; METHYL ETHERS; NEOPLASTIC STEM CELLS; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84928905405     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu402     Document Type: Article

References (30)

1. Santamaria LB, Schifilliti D, La Torre D, Fodale V. Drugs of anaesthesia and cancer. Surg Oncol 2010; 19: 63-81
2. Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 2010; 105: 106-15
3. Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M. Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg 2010; 110: 1636-43
4. Tsuchiya Y, Sawada S, YoshiokaI, et al. Increased surgical stress promotes tumor metastasis. Surgery 2003; 133: 547-55
5. Christopherson R, James KE, Tableman M, Marshall P, Johnson FE. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg 2008; 107: 325-32
6. Tavare AN, Perry NJ, Benzonana LL, Takata M, Ma D. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer 2012; 130: 1237-50
7. Moudgil GC, Singal DP. Halothane and isoflurane enhance melanoma tumour metastasis in mice. Can J Anaesth 1997; 44: 90-4
8. Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth 2009; 103: 685-90
9. Kawaraguchi Y, Horikawa YT, Murphy AN, et al. Volatile anesthetics protect cancer cellsagainst tumornecrosis factor-relatedapoptosisinducing ligand-induced Apoptosis via Caveolins. Anesthesiology 2011; 115: 499-508
10. Jun R, Gui-He Z, Xing-Xing S, Hui Z, Li-Xian X. Isoflurane enhances malignancy of head and neck squamous cell carcinoma cell lines: a preliminary study in vitro. Oral Oncol 2011; 47: 329-33
11. Benzonana LL, Perry NJ, Watts HR, et al. Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro. Anesthesiology 2013; 119: 593-605
12. Reya T, Morrison SJ, ClarkeMF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11
13. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer 2006; 6: 425-36
14. Li Z, Bao S, Wu Q, et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009; 15: 501-13
15. Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008; 15: 678-85
16. Soeda A, Park M, Lee D, et al. Hypoxia promotes expansion of the CD133-positive glioma stemcells throughactivation of HIF-1alpha. Oncogene 2009; 28: 3949-59
17. ZhangS, Xie R, WanF, YeF, GuoD, LeiT. Identification ofU251glioma stem cells and their heterogeneous stem-like phenotypes. Oncol Lett 2013; 6: 1649-55
18. Campos B, Wan F, Farhadi M, et al. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 2010; 16: 2715-28
19. Kvolik S, Dobrosevic B, Marczi S, Prlic L, Glavas-Obrovac L. Different apoptosis ratios and gene expressions in two human cell lines after sevoflurane anaesthesia. Acta Anaesthesiol Scand 2009; 53: 1192-9
20. Kvolik S, Glavas-Obrovac L, Bares V, Karner I. Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. Life Sci 2005; 77: 2369-83
21. Liang H, Gu MN, Yang CX, Wang HB, Wen XJ, Zhou QL. Sevoflurane inhibits proliferation, induces apoptosis, and blocks cell cycle progression of lung carcinoma cells. Asian Pac J Cancer Prev 2011; 12: 3415-20
22. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401
23. Holland EC. Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA 2000; 97: 6242-4
24. Zhang S, Luo X, Wan F, Lei T. The roles of hypoxia-inducible factors in regulating neural stem cells migration to glioma stem cells and determinating their fates. Neurochem Res 2012; 37: 2659-66
25. Mendez O, Zavadil J, Esencay M, et al. Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Mol Cancer 2010; 9: 133
26. Majumder PK, Febbo PG, Bikoff R, et al.mTORinhibition reverses Aktdependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 2004; 10: 594-601
27. ParkDM, Rich JN. Biologyof gliomacancer stemcells. MolCells 2009; 28: 7-12
28. Philip B, Ito K, Moreno-Sanchez R, Ralph SJ. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression. Carcinogenesis 2013; 34: 1699-707
29. Borovski T, De Sousa EMF, Vermeulen L, Medema JP. Cancer stem cell niche: the place to be. Cancer Res 2011; 71: 634-9
30. Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H. The brain tumor microenvironment. Glia 2012; 60: 502-14